Clinical Trial Update: Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of saquinavir in patients with chronic indinavir-associated nephrotoxicity; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Indinavir-associated Nephrotoxicity

Drugs mentioned

• Saquinavir (saquinavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: IDV Associated Nephrotoxicity | Phase 2 | Status: COMPLETED